The next vaccine? Discovered by AI

Big tech has been inching into healthcare, and now Google’s Alphabet is set on AI-drug discovery. With its recent formation of Isomorphic Laboratories, Alphabet is building on research by artificial intelligence lab DeepMind, acquired by Google in 2014. Pharmaceutical empires are pairing with tech giants to process massive amounts of medical data and research to spot promising therapies. The market for drug discovery technologies is expected to grow from $69.8 billion in 2020 to $110.4 billion by 2025, creating unprecedented speed, scale, and discovery of drugs and therapeutics from the ground up. It’s projected that pharmaceutical industries could boost profits by up to 45 percent by investing in AI.

 
 

Machine learning and AI is speeding up drug development research and discovery at a massive scale, and rendering tech giants a growing part of the healthcare system.